EHF and prostate cancer: As reported above, logistic regression analysis associated the EHF expression in primary prostate cancer with a risk of developing metastatic lesions within 5 years from the diagnosis, establishing a threshold value of 40% of positive cells, beyond which the risk increases 40-fold.